APA (7th ed.) Citation

Kempter, T., Richter-Pechańska, P., Michel, K., Rausch, T., Erarslan-Uysal, B., Eckert, C., . . . Kulozik, A. (2025). Subclonal TP53 and KRAS variants combined with poor treatment response identify ultrahigh-risk pediatric patients with T-ALL. Blood advances, 9(6), . https://doi.org/10.1182/bloodadvances.2024014209

Chicago Style (17th ed.) Citation

Kempter, Tamara, et al. "Subclonal TP53 and KRAS Variants Combined with Poor Treatment Response Identify Ultrahigh-risk Pediatric Patients with T-ALL." Blood Advances 9, no. 6 (2025). https://doi.org/10.1182/bloodadvances.2024014209.

MLA (9th ed.) Citation

Kempter, Tamara, et al. "Subclonal TP53 and KRAS Variants Combined with Poor Treatment Response Identify Ultrahigh-risk Pediatric Patients with T-ALL." Blood Advances, vol. 9, no. 6, 2025, https://doi.org/10.1182/bloodadvances.2024014209.